Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate analysis of the French Sarcoma Group Database

Annals of Oncology

Volumn 21, Issue 12, 2010, Pages 2436-2441

  Italiano, A ^a   Delva, F ^a,b   Mathoulin Pelissier, S ^a,b   Le Cesne, A ^c   Bonvalot, S ^c   Terrier, P ^c   Trassard, M ^d   Michels, J J ^e   Blay, J Y ^f   Coindre, J M ^a   Bui, B ^a  

^a INSTITUT BERGONIÉ   (France)

^b Centre of Clinical Investigation Clinical Epidemiology   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CENTRE RENÉ HUGUENIN   (France)

^e CENTRE FRANÇOIS BACLESSE   (France)

^f CENTRE LÉON BÉRARD   (France)

Author keywords

Adjuvant chemotherapy; Grade; Sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; METASTASIS POTENTIAL; MONOTHERAPY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESEARCH DESIGN; SARCOMA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 78649491471     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq238     Document Type: Article

References (13)

1. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997; 50: 647-654.
2. Pervaiz N, Colterjohn N, Farrokhyar F et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113: 73-81.
3. Woll PJ, Van Glabbeke M, Hohenberger P et al. Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): interim analysis of a randomised phase III trial. J Clin Oncol 2007; 25 (suppl) (Abstr 10008).
4. Coindre JM, Terrier P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14(3): 869-877.
5. Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-362.
6. Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-1926.
7. Fletcher C, Unni K, Mertens F. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press 2002.
8. Trojani M, Contesso G, Coindre JM et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37-42.
9. Shuster JJ. Median follow-up in clinical trials. J Clin Oncol 1991; 9: 191-192.
10. Stoeckle E, Coindre JM, Kantor G et al. Quality of surgery in soft tissue sarcoma: a single centre experience with the French Sarcoma Group (FSG) surgical system. Cancer Ther 2005; 3: 31-39.
11. Cormier JN, Huang X, Xing Y et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 2004; 22: 4567-4574.
12. Schoenfeld D. Chi-squared goodness it fit test for the proportional hazards regression. Biometrika 1981; 67: 147-153.
13. Andre F, Khalil A, Slimane K et al. Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer. J Clin Oncol 2005; 23: 2996-3000.